Senseonics Holdings (SENS) Debt to Equity (2014 - 2024)

Senseonics Holdings (SENS) reported Debt to Equity of $0.01 for Q1 2024, up 169.28% quarter-over-quarter from -$0.01 in Q4 2022.

Senseonics Holdings (SENS) Debt to Equity (2014 - 2024) Analysis & Trends

Senseonics Holdings (SENS) has 8 years of Debt to Equity data on file, last reported at $0.01 in Q1 2024.

Debt to Equity for Q1 2024 came in at $0.01, changed N/A year-over-year; the trailing twelve-month figure through Mar 2024 was $0.01 (changed N/A YoY), and the FY2022 annual result was -$0.01, changed N/A from the prior year.
Debt to Equity rose to $0.01 in Q1 2024 per SENS's latest filing, from -$0.01 in the prior quarter.
Over five years, Debt to Equity peaked at $0.03 in Q2 2022 and troughed at -$0.02 in Q3 2022.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt/Equity (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn	0.65
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn	0.64
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn	0.57
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn	0.42
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn	0.06
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	0.71
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn	-
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn	0.95
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn	0.27
10	Senseonics Holdings	309.99 Mn	245.67 Mn	6.94 Mn	-

Historic Data

Download Data

Date	Value
Mar 31, 2024	0.01
Dec 31, 2022	-0.01
Sep 30, 2022	-0.02
Jun 30, 2022	0.03
Mar 31, 2022	-0.02
Dec 31, 2019	-6.98
Sep 30, 2019	1.70
Mar 31, 2019	0.05
Dec 31, 2018	0.07
Sep 30, 2018	0.09
Jun 30, 2018	0.09
Mar 31, 2018	-0.91
Dec 31, 2017	1.98
Sep 30, 2017	0.76
Jun 30, 2017	1.60
Mar 31, 2017	-1.28
Dec 31, 2016	-3.11
Sep 30, 2016	3.07
Jun 30, 2016	1.01
Mar 31, 2016	0.38